Watchful waiting: new study tracks rare tumor growth without immediate treatment
NCT ID NCT01801176
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 100 adults with a rare, non-cancerous tumor called peripheral primitive fibromatosis. Instead of treating everyone right away, doctors monitored patients closely to see how the tumors behaved over three years. The goal was to learn which factors might predict tumor growth and to record what treatments were used if the tumor got worse.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL PRIMITIVE FIBROMATOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Gustave Roussy
Villejuif, Val de Marne, 94805, France